SCHEMBL23977677

SCHEMBL23977677

CSc1ccc(NC(=O)Nc2ccc(C#N)cn2)cc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 7/20 0.53
SMN1; SMN2 Q16637 5/20 0.53
MAPT P10636 5/20 0.53
NPC1 O15118 4/20 0.53
LMNA P02545 3/20 0.53
ALDH1A1 P00352 2/20 0.53
GBA1 P04062 1/20 0.53
TP53 P04637 1/20 0.53
CYP1A2 P05177 1/20 0.53
CYP2C19 P33261 1/20 0.53
NOX1 Q9Y5S8 1/20 0.48
L3MBTL1 Q9Y468 1/20 0.47
MEN1 O00255 4/20 0.47
KMT2A Q03164 4/20 0.47
TSHR P16473 1/20 0.47
HTT P42858 1/20 0.47
NLRP3 Q96P20 1/20 0.47
SAE1 Q9UBE0 1/20 0.46
UBA2 Q9UBT2 1/20 0.46
KDM4E B2RXH2 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4112875 0.82 RAB9A (0.57) RAB9ASMN1; SMN2MAPTNPC1LMNA
SCHEMBL23977709 0.81 RAB9A (0.70) RAB9ASMN1; SMN2MAPTNPC1LMNA
SCHEMBL23977983 0.77 NOX1 (0.55) RAB9ASMN1; SMN2MAPTNPC1LMNA
SCHEMBL1430551 0.74 KMT2A (0.57) CYP1A2L3MBTL1MEN1KMT2ADYRK3
SCHEMBL24008310 0.74 NPC1 (0.69) RAB9ASMN1; SMN2MAPTNPC1LMNA
SCHEMBL20941577 0.74 USP30 (0.52) RAB9ASMN1; SMN2MAPTLMNAMEN1
SCHEMBL25990087 0.74 MEN1 (0.48) SMN1; SMN2LMNAALDH1A1MEN1KMT2A
SCHEMBL3715011 0.73 MEN1 (0.58) RAB9AMAPTMEN1KMT2ADYRK3
SCHEMBL11054945 0.72 MAPT (0.81) RAB9ASMN1; SMN2MAPTLMNAALDH1A1
SCHEMBL31125142 0.72 PLCG2 (0.47) RAB9ASMN1; SMN2MAPTNPC1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230219893-A1 Krüppel-Like Factor 15 (KLF15) Small Molecule Agonists in Kidney Disease US GOV VETERANS AFFAIRS (US) 2023-07-13 US disclosed
US-20230219893-A1 Krüppel-Like Factor 15 (KLF15) Small Molecule Agonists in Kidney Disease US GOV VETERANS AFFAIRS (US) 2023-07-13 US disclosed
US-11643394-B2 Krüppel-like factor 15 (KLF15) small molecule agonists in kidney disease ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI (US) 2023-05-09 US disclosed
US-11643394-B2 Krüppel-like factor 15 (KLF15) small molecule agonists in kidney disease ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI (US) 2023-05-09 US disclosed
US-20210347734-A1 Krüppel-Like Factor 15 (KLF15) Small Molecule Agonists in Kidney Disease THE RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK 2021-11-11 US disclosed
WO-2021222637-A1 KRÜPPEL-LIKE FACTOR 15 (KLF15) SMALL MOLECULE AGONISTS IN KIDNEY DISEASE UNITED STATES GOVERNMENT AS REPRESENTED BY THE DEPARTMENT OF VETERANS AFFAIRS (US) 2021-11-04 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11643394-B2 Krüppel-like factor 15 (KLF15) small molecule agonists in kidney disease KIF15, KLF5, KLF10 RAB9A 1697/4885SMN1; SMN2 45/4885MAPT 43/4885
US-20230219893-A1 Krüppel-Like Factor 15 (KLF15) Small Molecule Agonists in Kidney Disease KIF15, KLF5, KLF10 RAB9A 1697/4885SMN1; SMN2 45/4885MAPT 43/4885
US-20210347734-A1 Krüppel-Like Factor 15 (KLF15) Small Molecule Agonists in Kidney Disease KIF15, KLF5, KLF10 RAB9A 1697/4885SMN1; SMN2 45/4885MAPT 43/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.